Lotus Pharmaceutical Co Ltd
TWSE:1795

Watchlist Manager
Lotus Pharmaceutical Co Ltd Logo
Lotus Pharmaceutical Co Ltd
TWSE:1795
Watchlist
Price: 282 TWD 0.18%
Market Cap: 74.8B TWD
Have any thoughts about
Lotus Pharmaceutical Co Ltd?
Write Note

Lotus Pharmaceutical Co Ltd
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Lotus Pharmaceutical Co Ltd
Total Receivables Peer Comparison

Comparables:
Y
3705
4746
1789
S
4119
1720

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Lotus Pharmaceutical Co Ltd
TWSE:1795
Total Receivables
NT$6.4B
CAGR 3-Years
16%
CAGR 5-Years
27%
CAGR 10-Years
21%
Y
YungShin Global Holding Corp
TWSE:3705
Total Receivables
NT$1.8B
CAGR 3-Years
3%
CAGR 5-Years
-2%
CAGR 10-Years
1%
Formosa Laboratories Inc
TWSE:4746
Total Receivables
NT$1.2B
CAGR 3-Years
20%
CAGR 5-Years
9%
CAGR 10-Years
4%
ScinoPharm Taiwan Ltd
TWSE:1789
Total Receivables
NT$494.2m
CAGR 3-Years
5%
CAGR 5-Years
-1%
CAGR 10-Years
-7%
S
SCI Pharmtech Inc
TWSE:4119
Total Receivables
NT$368.8m
CAGR 3-Years
-18%
CAGR 5-Years
-4%
CAGR 10-Years
6%
Standard Chem & Pharm Co Ltd
TWSE:1720
Total Receivables
NT$1.7B
CAGR 3-Years
15%
CAGR 5-Years
11%
CAGR 10-Years
7%

See Also

What is Lotus Pharmaceutical Co Ltd's Total Receivables?
Total Receivables
6.4B TWD

Based on the financial report for Jun 30, 2024, Lotus Pharmaceutical Co Ltd's Total Receivables amounts to 6.4B TWD.

What is Lotus Pharmaceutical Co Ltd's Total Receivables growth rate?
Total Receivables CAGR 10Y
21%

Over the last year, the Total Receivables growth was 1%. The average annual Total Receivables growth rates for Lotus Pharmaceutical Co Ltd have been 16% over the past three years , 27% over the past five years , and 21% over the past ten years .

Back to Top